Literature DB >> 23231013

Bladder transitional cell carcinoma and BK virus in a young kidney transplant recipient.

L Pino1, E Rijo, G Nohales, A Frances, A Ubre, O Arango.   

Abstract

Kidney transplant recipients have a heightened risk of developing neoplasms. Immunosuppressive treatments decrease the incidence of transplant rejection but increase the risk of infections, including BK virus (BKV). This infection is acquired in childhood and remains latent in the renal and urinary epithelium. In cases of immunodeficiency, BKV has been implicated as a tumor virus, but the role of BKV in cancer is a controversial topic and is difficult to determine. In the tumor cells, it is possible to detect fragments of the viral genome that could alter the control mechanisms of the cell cycle and DNA repair. We report the case of a kidney transplant recipient who developed BKV nephropathy and carcinoma of the bladder, supporting a possible role for BKV in the oncogenic pathway in this clinical setting, but the role of BKV in cancer remains a controversial topic and difficult to determine.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Year:  2012        PMID: 23231013     DOI: 10.1111/tid.12042

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  9 in total

Review 1.  The case for BK polyomavirus as a cause of bladder cancer.

Authors:  Gabriel J Starrett; Christopher B Buck
Journal:  Curr Opin Virol       Date:  2019-07-20       Impact factor: 7.090

2.  Upper urinary tract urothelial carcinoma behaviors in patients with end-stage renal disease after kidney transplantation in Taiwan.

Authors:  Chia-Shen Chien; Hao Lun Luo; Chou Shu Ling; Po-Hui Chiang; Yen-Ta Chen; Yuan Tso Cheng
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

Review 3.  A cornucopia of human polyomaviruses.

Authors:  James A DeCaprio; Robert L Garcea
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

4.  Survey for human polyomaviruses in cancer.

Authors:  Tuna Toptan; Samuel A Yousem; Jonhan Ho; Yuki Matsushima; Laura P Stabile; Maria-Teresa Fernández-Figueras; Rohit Bhargava; Akihide Ryo; Patrick S Moore; Yuan Chang
Journal:  JCI Insight       Date:  2016-02-25

5.  The oncogenic potential of BK-polyomavirus is linked to viral integration into the human genome.

Authors:  Daniel J Kenan; Piotr A Mieczkowski; Raquel Burger-Calderon; Harsharan K Singh; Volker Nickeleit
Journal:  J Pathol       Date:  2015-08-19       Impact factor: 7.996

6.  Treatment for presumed BK polyomavirus nephropathy and risk of urinary tract cancers among kidney transplant recipients in the United States.

Authors:  Gaurav Gupta; Sarat Kuppachi; Roberto S Kalil; Christopher B Buck; Charles F Lynch; Eric A Engels
Journal:  Am J Transplant       Date:  2017-11-01       Impact factor: 9.369

7.  Metachronous urothelial carcinoma of whole urinary tract in a dialysis-dependent patient: A case report.

Authors:  Yimin Wang; Baiye Jin; Xiaolin Yao
Journal:  Oncol Lett       Date:  2016-05-06       Impact factor: 2.967

Review 8.  BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection.

Authors:  Darlene Vigil; Nikifor K Konstantinov; Marc Barry; Antonia M Harford; Karen S Servilla; Young Ho Kim; Yijuan Sun; Kavitha Ganta; Antonios H Tzamaloukas
Journal:  World J Transplant       Date:  2016-09-24

Review 9.  Role of BK human polyomavirus in cancer.

Authors:  Jorge Levican; Mónica Acevedo; Oscar León; Aldo Gaggero; Francisco Aguayo
Journal:  Infect Agent Cancer       Date:  2018-04-05       Impact factor: 2.965

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.